news
Bristol-Myers Squibb announces changes in senior management team
19 October 2011 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company announced a series of related changes within its Senior Management Team...
List view / Grid view
Bristol-Myers Squibb Company
news
KOMBOGLYZE™ receives positive CHMP opinion in the European Union for the treatment of type 2 diabetes
23 September 2011 | By AstraZeneca
KOMBOGLYZE™ receives a positive opinion from CHMP...
news
Bristol-Myers Squibb and Ono enter into strategic agreement
20 September 2011 | By Bristol-Myers Squibb
Strategic agreement for Anti-PD-1 Antibody, BMS-936558/ONO-4538, and ORENCIA® (abatacept)...
news
Bristol-Myers Squibb completes acquisition of Amira Pharmaceuticals
8 September 2011 | By Bristol-Myers Squibb Company
Bristol-Myers Squibb Company has completed its previously announced acquisition of privately held Amira Pharmaceuticals, Inc...
news
New data from Bristol-Myers Squibb on NULOJIX® (belatacept)
1 September 2011 | By Bristol-Myers Squibb
Data to be presented at the 2011 European Society for Organ Transplantation Congress...
news
ICON selected as a preferred provider for early phase clinical development by Bristol-Myers Squibb
31 August 2011 | By ICON plc
Agreement builds on existing strategic partnership for global clinical development...
news
ELIQUIS® (apixaban) superior to Warfarin for the reduction of stroke or systemic embolism
28 August 2011 | By Bristol-Myers Squibb Company, Pfizer
Significantly less major bleeding in patients with Atrial Fibrillation in Phase 3 ARISTOTLE trial...
news
Bristol-Myers Squibb and Pfizer announce data presentations
23 August 2011 | By Pfizer
New data presentations from largest Phase 3 Clinical Trial Program for Stroke Prevention in Atrial Fibrillation...
news
Bristol-Myers Squibb announces winners of “Fight HIV Your Way” contest
16 August 2011 | By Bristol-Myers Squibb Company
Winners of the 2011 REYATAZ® (atazanavir sulfate) “Fight HIV Your Way” contest announced...
news
U.S. FDA approves subcutaneous formulation of ORENCIA® (abatacept)
29 July 2011 | By Bristol-Myers Squibb
ORENCIA® (abatacept) treatment for adults with moderate to severe rheumatoid arthritis (RA)...
news
Bristol-Myers Squibb to acquire Amira Pharmaceuticals
21 July 2011 | By Bristol-Myers Squibb
Bristol-Myers Squibb will acquire privately held Amira Pharmaceuticals, a small-molecule pharmaceutical company...
news
FDA Advisory Committee makes recommendation on investigational compound dapagliflozin
20 July 2011 | By AstraZeneca
FDA Endocrinologic and Metabolic Drugs Advisory Committee meeting outcome...
news
YERVOY™ (ipilimumab) approved for the treatment of previously-treated advanced melanoma in the EU
14 July 2011 | By Bristol-Myers Squibb
The European Commission has approved YERVOY™ (ipilimumab)...
news
Investigational compound DAPAGLIFLOZIN sustained glycemic control and weight reduction
27 June 2011 | By AstraZeneca
Results from an exploratory 78-week study...
news
Bristol-Myers Squibb Foundation awards $1.5 million in grants to help African American women fight type 2 diabetes
24 June 2011 | By Bristol-Myers Squibb
The Bristol-Myers Squibb Foundation awarded five grants totaling $1.5 million...
